(Eds.) Balch, C.M., Milton, G.W., Shaw, H.M., Soong, S.J. 1985, pp. 407- 
418. 
8. Wallack, M., Bash, J., Leftheriotis, E., Seigler, H.F., Bland, I., Waneobo, 
H., Balch, C. Positive relationship of clinical and serological responses 
to vaccinia melanoma oncolysate. Arch. Surg., 1987, 122: 1460-1463. 
9. Darrow, T.L., Slingluff, C.L., Seigler, H.F. The role of HLA Class I 
antigens in recognition of melanoma cells by tumor-specific cytotoxic 
T-lymphocytes: Evidence for shared tumor antigens. J Immuno., 1989, 
142(9): 3329-3335. 
10. Slingluff, C.L., Darrow, T.L., Seigler, H.F. Melanoma-specific cytotoxic 
T-cells generated from peripheral blood lymphocytes: Implications of a 
renewable source of recursors for adoptive cellular immunotherapy. 
Ann. Surg., 1989, 210(2): 194-202. 
11. Crowley, N.J., Vervaert, C.E., Seigler, H.F. Treatment of human 
melanoma hepatic metastases in nude mice with human CTLs. Arch. 
Surg., 1991, 126: 433-437. 
12. Fearon E., Pardoll D., Itaya T., Golumbek P., Levitsky H., Simons J., 
Karasuyama H., Vogelstein B., and Frost P., Interleukin-2 production by 
tumor cells bypasses T helper function in the generation of an 
antitumor response. Cell, 60:397-403, 1990. 
13. Gansbacher B., Zier K., Daniels B., Cronin K., Bannerji R., and Gilboa 
E., Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity 
and induces protective immunity. J. Exp. Med. 172:1217-1224, 1990. 
14. Golumbek P., Lazenby A., Levitsky H., Jaffee L., Karasuyama H., Baker 
M., Pardoll D., Treatment of established renal cancer by tumor cells 
engineered to secrete interleukin-4. Science 254:713-716, 1991. 
15. Tepper R., Pattengale P., and Leder P., Murine interleukin-4 displays 
potent anti-tumor activity in vivo. Cell 57:503-512, 1989. 
16. Watanabe Y., Kuribayashi K., Miyatake S., Nishihara K., Nakayama E-I., 
Taniyama T., and Sakata T., Exogenous expression of mouse interferon 
gamma cDNA in mouse neuroblastoma C1300 cells results in reduced 
tumorigenicity by augmented anti-tumor immunity. Proc. Natl. Acad. 
Sci. USA 86:9456-9460, 1989. 
17. Gastl, G., Finstad, C.L., Guarini, A., Bosl, G., Gilboa, E., Bander, N.H., 
and Gansbacher, B. Retroviral vector-mediated lymphokine gene 
transfer into human renal cancer cells. Cancer Res. 52, 6229-6236 (1992). 
18. Gansbacher, B., Bannerji, R., Daniels, B., Zier, K., Cronin, K., and 
Gilboa, E. Retroviral vector-mediated gamma-interferon gene transfer 
into tumor cells generates potent and long-lasting anti-tumor 
immunity. Cancer Res. 50, 7820-7825 (1990). 
Recombinant DNA Research, Volume 20 
[265] 
